XHE
State Street SPDR S&P Health Care Equipment ETF
SPDR S&P Health Care Equipment ETF is an exchange-traded fund incorporated in the USA. The Fund's objective is to replicate as closely as possible the performance of the S&P Health Care Equipment Select Industry Index.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 152.6 M
ASSETS UNDER MGMT
35 bp
EXPENSES
Fund Basics
| Inception date | Jan 26, 2011 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| GLAUKOS CORP | 2.1 % |
| INTUITIVE SURGICAL INC | 1.9 % |
| GE HEALTHCARE TECHNOLOGIES INC. | 1.9 % |
| HAEMONETICS CORP/MASS | 1.8 % |
| ATRICURE INC | 1.8 % |
| BECTON DICKINSON AND CO | 1.7 % |
| OMNICELL INC | 1.7 % |
| INSULET CORP | 1.7 % |
| IDEXX LABORATORIES INC | 1.7 % |
| EDWARDS LIFESCIENCES CORP | 1.7 % |
Constituent Breakdown
| Number of holdings | 68 |
| Herfindahl-Hirschman Index | 149 |
| Wgt avg mkt cap (mns) | $18,102 |
| Large cap (>$10bn) | 30.7% |
| Mid cap ($2-10bn) | 32.2% |
| Small cap (<$2bn) | 31.9% |
| Developed mkts. | 95.6% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 89.6 % |
 |
IRELAND | 3.3 % |
 |
BRITAIN | 2.9 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 2.8% | 15.2% | 0.1% | 5.1% | -6.2% | 5.7% | -- | 8.5% |
| Dividend Yield | 0.0% | 0.0% | 0.1% | 0.1% | 0.0% | 0.1% | -- | 0.9% |
| Total Returns | 2.8% | 15.2% | 0.2% | 5.2% | -6.2% | 5.9% | -- | 9.4% | Ann. Volatility | 23.5% | 22.6% | 22.6% | 22.3% | 24.8% | 23.2% | -- | 21.3% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.84 | 23% |
| MSCI EAFE | 0.65 | 21% |
| MSCI Emg Mkts | 0.23 | 6% |
Liquidity Measures
| Avg. volume (000) | 35 |
| ADV traded (mns) | $3 |
| Turnover | 2.1% |
| Avg. Bid/Ask (% of price) | 0.20% |
Technical Indicators
| 30d moving avg. (EMA) | $91.67 |
| Relative strength (RSI) | 50 |
| MACD/Signal | 0.61/0.30 |
| Bollinger Bands (Upper/Lower) | $94.99/$87.31 |
| Short interest (% of AUM) | 27.7% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. XHE |
Expenses vs. XHE |
ALTAR Score™ vs. XHE |
|---|---|---|---|---|
| IHI | iShares U.S. Medical Devices ETF | 35.9% | +2 bp | +3.6% |
| MDEV | First Trust Indxx Medical Devices ETF | 35.9% | +35 bp | +3.6% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 28.4% | +5 bp | +5.1% |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | 26.6% | +45 bp | -0.1% |
| FXH | First Trust Health Care AlphaDEX Fund | 21.3% | +26 bp | +4.0% |
| PSCH | Invesco S&P SmallCap Health Care ETF | 19.4% | -6 bp | +1.4% |
| HEAL | Global X HealthTech ETF | 18.6% | +15 bp | -2.2% |
| EKG | First Trust Nasdaq Lux Digital Health Solutions ETF | 14.4% | +30 bp | -1.6% |
| VHT | Vanguard Health Care ETF | 13.4% | -26 bp | +3.4% |
| FHLC | Fidelity MSCI Health Care Index ETF | 13.2% | -27 bp | +3.6% |
Risk and Returns: XHE vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/4/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
1.3%
ALTAR SCORE™
2nd
PERCENTILE
AVOID
ETFRC RATING
There are 1,394 funds in the US Equity category with an average
ALTAR Score™ of 5.6% and a standard deviation
of 2.1%. XHE's ALTAR Score™ is approximately -2.0 standard
deviations above the category average. This places XHE in the 2nd percentile
among funds in the category.
Sell-Side Consensus
$115.11
PRICE TARGET
+24.4%
UPSIDE